Neomorph

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

TRIANA Biomedicines

This company develops molecular glue therapeutics for patients with cancer and other diseases using a discovery platform and computational tools.

Ternary Tx

Ternary Therapeutics develops an artificial intelligence platform to design molecular glue drugs for pharmaceutical companies targeting previously undruggable proteins linked to inflammatory diseases.

Molecular Glue Labs

This company develops artificial intelligence software and infrastructure to design small-molecule drugs that reprogram protein networks to treat previously untreatable diseases.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.

Plexium

This company develops targeted protein degradation therapeutics and discovery platforms for patients with cancer and neurodegenerative diseases.

Ternary Therapeutics

This company develops an artificial intelligence platform to design molecular glue therapeutics for healthcare providers and pharmaceutical partners to treat complex diseases.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.